We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
+8.69%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$393M
AUM Growth
+$20.1M
Cap. Flow
+$9.32M
Cap. Flow %
2.37%
Top 10 Hldgs %
14.62%
Holding
983
New
387
Increased
109
Reduced
91
Closed
395

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$12.3M
2
MRNA icon
Moderna
MRNA
+$5.95M
3
QCOM icon
Qualcomm
QCOM
+$4.24M
4
TAL icon
TAL Education Group
TAL
+$3.82M
5
AMD icon
Advanced Micro Devices
AMD
+$3.65M

Top Sells

Rank Stock Value
1
BIDU icon
Baidu
BIDU
+$3.44M
2
KMB icon
Kimberly-Clark
KMB
+$2.7M
3
MCO icon
Moody's
MCO
+$2.68M
4
UPS icon
United Parcel Service
UPS
+$2.64M
5
SHW icon
Sherwin-Williams
SHW
+$2.59M

Sector Composition

Rank Sector Weight
1 Healthcare 17.91%
2 Technology 17.83%
3 Consumer Discretionary 11.15%
4 Industrials 9.32%
5 Materials 8.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IP icon
201
International Paper
IP
$22.3B
$650K 0.17%
+11,197
New +$639K
AON icon
202
Aon
AON
$77.3B
$646K 0.16%
2,704
-1,167
-30% -$285K
PG icon
203
Procter & Gamble
PG
$343B
$640K 0.16%
+4,740
New +$641K
CF icon
204
CF Industries
CF
$19.2B
$636K 0.16%
12,365
+7,826
+172% +$398K
TRGP icon
205
Targa Resources
TRGP
$60.4B
$633K 0.16%
+14,250
New +$552K
WSM icon
206
Williams-Sonoma
WSM
$26.7B
$633K 0.16%
+7,928
New +$675K
TDG icon
207
TransDigm Group
TDG
$69.2B
$631K 0.16%
+975
New +$612K
OKE icon
208
Oneok
OKE
$58.7B
$628K 0.16%
11,279
+3,666
+48% +$195K
BSX icon
209
Boston Scientific
BSX
$65.8B
$626K 0.16%
14,634
+2,506
+21% +$105K
YUM icon
210
Yum! Brands
YUM
$41B
$625K 0.16%
5,437
-786
-13% -$92.7K
LRCX icon
211
Lam Research
LRCX
$382B
$621K 0.16%
+9,550
New +$603K
PCH
212
DELISTED
PotlatchDeltic
PCH
$618K 0.16%
+11,620
New +$670K
RY icon
213
Royal Bank of Canada
RY
$291B
$616K 0.16%
6,081
-315
-5% -$31.2K
BAX icon
214
Baxter International
BAX
$11.6B
$610K 0.16%
7,579
-24,965
-77% -$2.09M
TD icon
215
Toronto Dominion Bank
TD
$198B
$603K 0.15%
8,612
+5,384
+167% +$377K
CRSP icon
216
CRISPR Therapeutics
CRSP
$4.58B
$602K 0.15%
3,716
-3,732
-50% -$454K
COR icon
217
Cencora
COR
$60.3B
$601K 0.15%
+5,249
New +$620K
CME icon
218
CME Group
CME
$92.2B
$590K 0.15%
+2,772
New +$585K
FANG icon
219
Diamondback Energy
FANG
$57.6B
$589K 0.15%
+6,278
New +$517K
ESS icon
220
Essex Property Trust
ESS
$18.9B
$584K 0.15%
+1,945
New +$574K
HRC
221
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$584K 0.15%
+5,140
New +$575K
CPRI icon
222
Capri Holdings
CPRI
$1.77B
$582K 0.15%
+10,171
New +$553K
JLL icon
223
Jones Lang LaSalle
JLL
$15.1B
$581K 0.15%
+2,974
New +$581K
MHK icon
224
Mohawk Industries
MHK
$6.9B
$581K 0.15%
+3,022
New +$615K
NSC icon
225
Norfolk Southern
NSC
$78.8B
$578K 0.15%
2,178
+322
+17% +$88.9K

Similar funds

Y-Intercept (HK)'s Q2 2021 Portfolio in Review

As of Q2 2021, Y-Intercept (HK) held 983 positions worth $393M, up 5.4% from $373M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Y-Intercept (HK)'s Q2 2021 filing shows 387 new, 109 increased, 91 reduced and 395 closed positions. Its largest new stake was Linde: 42,339 shares worth $12.2M. The largest sale was Baidu, an estimated $3.44M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 14% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Y-Intercept (HK)'s largest Q2 2021 buy was Linde: 42,339 shares worth $12.2M.
  • Y-Intercept (HK) added most to Moderna in Q2 2021, an estimated $5.95M increase.
  • Y-Intercept (HK)'s biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $2.59M.
  • Y-Intercept (HK) fully exited Baidu in Q2 2021, selling an estimated $3.44M.
  • Y-Intercept (HK)'s ten largest holdings make up 15% of its $393M portfolio in Q2 2021.
  • Y-Intercept (HK) opened 387 new positions and closed 395 in Q2 2021.
  • Y-Intercept (HK)'s portfolio value rose 5.4% quarter-over-quarter to $393M.

Based on Y-Intercept (HK)'s 13F filing for Q2 2021, filed 12 Aug 2021.